Related Experiment Video
Updated: Dec 17, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
FB-15 inhibits MGC-803 cells growth by regulating energy metabolism
Xiangping Deng1, Yiyuan Pi2, Zhongli Li3
1Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang City, Hunan Province, PR China; Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang City, Hunan Province, PR China.
Abstract:
In this study, we scrutinized the anticancer effects of FB-15 on human gastric carcinoma MGC-803 cells in vitro and vivo, and its preliminary effect on tubulin and HIF-1α. We confirmed that FB-15 not only inhibited the proliferation of a large number of cells in a concentration and time-dependent manner but also inhibited proliferation of a single cell to form clones. FB-15 manifested little cytotoxicity for normal stomach cells GES-1. The flow cytometry analysis displayed that FB-15 induced apoptosis MGC-803 cells and mainly arrested cells in the S phase in a concentration-dependent manner. The results of the wound healing assay indicated that FB-15 suppressed cell migration. Furthermore, the western blotting showed that FB-15 down-regulated the expression of β3-tubulin and HIF-1α, consistent with Immunohistochemical assay. The binding modes of FB-15 with tubulin were clarified by molecular docking. FB-15 significantly suppressed the growth of MGC-803 gastric cancer tumors. The inhibitory effect of FB-15 on tumor growth was superior to 5-Fu. Taken together, these results provided evidence for FB-15 to be used as an effective anticancer drug candidate for gastric cancer.
Insights
FB-15 demonstrates significant anticancer effects against human gastric carcinoma MGC-803 cells by inhibiting proliferation, inducing apoptosis, and suppressing tumor growth. This compound shows potential as an effective gastric cancer therapeutic, outperforming 5-Fu.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Gastric cancer remains a significant global health challenge with limited effective therapeutic options.
- Identifying novel anticancer agents with improved efficacy and reduced toxicity is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the anticancer effects of FB-15 on human gastric carcinoma MGC-803 cells in vitro and in vivo.
- To elucidate the preliminary mechanisms of action, including effects on tubulin and hypoxia-inducible factor 1-alpha (HIF-1α).
Main Methods:
- In vitro studies involved cell proliferation assays, clone formation assays, cytotoxicity tests on normal gastric cells (GES-1), flow cytometry for apoptosis and cell cycle analysis, and wound healing assays for cell migration.
- In vivo studies utilized tumor xenograft models in mice.
- Western blotting and immunohistochemical assays were employed to assess protein expression levels of β3-tubulin and HIF-1α.
- Molecular docking was used to predict binding modes of FB-15 with tubulin.
Main Results:
- FB-15 inhibited MGC-803 cell proliferation and clone formation in a concentration- and time-dependent manner.
- FB-15 induced apoptosis and cell cycle arrest in the S phase in MGC-803 cells, with minimal cytotoxicity to normal GES-1 cells.
- FB-15 suppressed cell migration and down-regulated the expression of β3-tubulin and HIF-1α.
- Molecular docking revealed specific binding modes of FB-15 with tubulin.
- FB-15 significantly suppressed gastric cancer tumor growth in vivo, demonstrating superior efficacy compared to 5-fluorouracil (5-Fu).
Conclusions:
- FB-15 exhibits potent anticancer activity against human gastric carcinoma MGC-803 cells through multiple mechanisms, including antiproliferation, pro-apoptosis, anti-migration, and modulation of β3-tubulin and HIF-1α.
- FB-15 demonstrates significant in vivo efficacy in suppressing gastric cancer tumor growth, outperforming the current standard chemotherapy drug 5-Fu.
- These findings support FB-15 as a promising drug candidate for the development of novel therapeutics for gastric cancer.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
05:29A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021